Bronchoalveolar lavage alterations in pulmonary embolism

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 5 PART I, 1998, Pages 1504-1510

  Nakos, George ^a   Kitsiouli, Eirene I ^a   Lekka, Marilena E ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALBUMIN; LUNG SURFACTANT; LYSOPHOSPHATIDYLCHOLINE; OXYGEN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROTEIN; SPHINGOMYELIN; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG EMBOLISM; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; AGED; ALBUMINS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; LIPIDS; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; OXYGEN; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PLATELET ACTIVATING FACTOR; PROTEINS; PULMONARY EMBOLISM; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL;

EID: 0031730983     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.5.9802036     Document Type: Article

References (44)

1. D'Angelo, E. 1997. Advance in basic laboratory and clinical aspects of thromboembolic diseases: lung mechanics and gas exchange in pulmonary embolism. Haematologica 82:371-374.
2. Wilson, J. E., A. K. Pierce, and R. L. Johnson. 1971. Hypoxemia in pulmonary embolism: a clinical study. J. Clin. Invest. 50:481-491.
3. D'Alonzo, G. E., and D. R. Dantzker. 1986. Gas exchange alterations following pulmonary thromboembolism. Clin. Chest Med. 5:411-419.
4. Manier, G. Y., Y. Castaing, and G. H. Guenard. 1985. Determinants of hypoxemia during acute phase of pulmonary embolism in humans. Am. Rev. Respir. Dis. 132:332-338.
5. Murphy, S. S., A. M. Losasso, and A. S. Gibbs. 1978. Acquired right to left shunt in severe hypoxemia. Crit. Care Med. 6:28-31.
6. Chernick, V., W. H. Hodson, and L. J. Greenfield. 1966. Effects of chronic pulmonary artery ligation on pulmonary mechanisms and surfactant. J. Appl. Physiol. 21:1315-1320.
7. Levy, S. E., and D. H. Simmons. 1974. Redistribution of alveolar ventilation following pulmonary thromboembolism in dogs. J. Appl. Physiol. 36:60-68.
8. Levy, S. E., and D. H. Simmons. 1975. Mechanism of arterial hypoxia following pulmonary thromboembolism in dogs. J. Appl. Physiol. 39:41-46.
9. Delcroix, M., C. Melot, F. Vermeulen, and R. Naeije. 1996. Hypoxic pulmonary vasoconstriction and gas exchange in acute canine pulmonary embolism. J. Appl. Physiol. 80:1240-1248.
10. Hanahan, D. J. 1986. Platelet-activating factor, a biologically active phosphoglyceride. Annu. Rev. Biochem. 55:483-509.
11. Voelkel, N. F., K. R. Stenmark, J. T. Reeves, M. M. Mathias, and R. C. Murphy. 1982. Nonimmunologic production of leukotrienes induced by platelet-activating factor. Science 218:286-288.
12. Smith, C. S., L. Parker, and W. T. Shearer. 1994. Cytokines regulation by platelet-activating factor in a human B cell lines. J. Immunol. 153:3997-4005.
13. Tarbet, E. B., D. M. Stafforini, M. R. Elstad, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. (1991). Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J. Biol. Chem. 266:16667-16673.
14. Van Golde, L. M. G., J. J. Batenburg, and B. Robertson. 1988. The pulmonary surfactant system. Physiol. Rev. 68:374-455.
15. The PIOPED investigators. 1990. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). J.A.M.A. 263:2753-2759.
16. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
17. Doumas, B. T., and H. G. Biggs. 1972. Determiantion of serum albumin. In G. A. Cooper, editor. Standard Methods of Clinical Chemistry, Vol. 7. Academic Press, New York. 175.
18. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. PhysioL 37:911-917.
19. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466-168.
20. Bossant, M.-J., E. Ninio, D. Delautier, and J. Benveniste. 1990. Bioassay of paf-acether by rabbit platelet aggregation. Methods Enzymol. 187:125-130.
21. Tselepis, A. D., M. L. Lekka, and D. A. Tsoukatos. 1991. PAF-acetylhydrolase activity in Tetrahymena pyriformis cells. FEBS Lett. 288:147-150.
22. Von Wichert, P., K. Joseph, B. Muller, and W. M. Frank. 1993. Bronchoalveolar lavage: quantification of intraalveolar fluid. Am. Rev. Respir. Dis. 147:148-152.
23. Malik, A. B., and H. Van der Zee. 1978. Mechanism of pulmonary edema induced by microembolization in dogs. Circ. Res. 42:72-79.
24. Ohkuda, K., K. Nakahara, and W. J. Weidner. 1978. Lung fluid exchange after uneven pulmonary artery obstruction in sheeps. Circ. Res. 43:152-161.
25. Johnson, A., and A. B. Malik. 1981. Effect of different size microemboli on lung fluid and protein exchange. J. Appl. Physiol. 51:461-464.
26. Hida, W., and J. Hildebrandt. 1984. Alveolar surface tension, lung infla-tion, and hydration effect interstitial pressure [Px(f)]. J. Appl. Physiol. 57:262-270.
27. Nakos, G., J. Pneumatikos, H. Tsangaris, K. Telis, and M. E. Lekka. 1997. Protein and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am. J. Respir. Crit. Care Med. 155:945-951.
28. Bredenberg, C. E., G. F. Nieman, A. M. Paskanik, and A. K. E. Hart. 1986. Microvascular membrane permeability in high surface tension pulmonary edema. J. Appl. Physiol. 60:253-259.
29. Wang, C. Z., R. E. Barrow, C. S. Cox, Jr., S. F. Yang, and D. N. Herndon. 1993. Influence of detergent aerosol on lung microvascular permeability. J. Appl. Physiol. 74:1016-1023.
30. Wright, J. R., and L. G. Dodds. 1991. Regulation of pulmonary surfactant secretion and clearance. Annu. Rev. Physiol. 53395-414.
31. Oyarzun, M. J., and J. A. Clements. 1978. Control of lung surfactant by ventilation, adrenergic mediators and prostaglandins in the rabbit. Am. Rev. Respir. Dis. 117:879-891.
32. Veldhuizen, R. A. W., L. A. McCaig, T. Akino, and J. F. Lewis. 1995. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152:1867-1871.
33. Fukahori, M., T. Murata, M. U. Mohammed, N. Fukuyama, and H. Nakazawa. 1997. Early reperfusion induces alveolar injury in pulmonary embolism. Chest 111:198-203.
34. Kikkawa, Y., and F. Smith. 1983. Cellular and biochemical aspects of pulmonary surfactant in health and disease. Lab. Invest. 49:122-139.
35. Caldini, P. 1965. Pulmonary hemodynamics and arterial oxygen saturation in pulmonary embolism. J. Appl. Physiol. 20:184-190.
36. Raschke, P., and B. F. Becker. 1995. Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia. Cardiovasc. Res. 29:569-576.
37. Evans, T. W., K. F. Chung, D. F. Rogers, and P. J. Barnes. 1987. Effect of platelet-activating factor on airway vascular permeability: possible mechanism. J. Appl. Physiol. 63:479-484.
38. Sakai, A., S. Chang, and N. F. Voelkel. 1989. Importance of vasocon-striction in lipid mediator-induced pulmonary edema. J. Appl. Physiol. 66:2667-2674.
39. Cuss, F. M., C. M. S. Dixon, and P. J. Barnes. 1986. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2:189-192.
40. Gillespie, M. N., and B. D. Bowdy. 1986. Impact of platelet activating factor on vascular responsiveness in isolated rat lung. J. Pharmacol. Exp. Ther. 236:396-402.
41. Bussolino, F., and G. Camussi. 1995. Platelet activating factor produced by endothelial cells: a molecule with autocrine and paracrine properties. Eur. J. Biochem. 229:327-337.
42. Lekka, M. L., A. Tokumura, H. Tsuji, and D. J. Hanahan. 1993. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol. Arch. Biochem. Biophys. 302:380-384.
43. Tarbet, E. B., D. M. Stafforini, M. R. Elstad, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1991. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J. Biol. Chem. 266:16667-16673.
44. Nakos, G., E. I. Kitsiouli, I. Tsangaris, and M. E. Lekka. 1998. Bronchoalveolar lavage fluid characteristics of early intermediate and late phase of ARDS: alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med. 24:296-303.